Milk calcium oral flash disintegrating tablet for pets as well as preparation method and application of milk calcium oral flash disintegrating tablet
Patent Information
- Application Number
- CN202411135225.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-19
- Publication Date
- 2024-11-01
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of pharmaceuticals, and in particular relates to an oral flash-disintegrating tablet of pet calcium milk, and a preparation method and application thereof. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Milk calcium, also known as whey calcium, is a milky white powder obtained by processing cow's milk through membrane permeation, separation, concentration and spray drying. Its main components are calcium phosphate, calcium citrate and ionic calcium. In addition, it also includes protein, lactose, zinc, phosphorus, sodium, potassium, magnesium and other ingredients. The calcium content is about 23% to 28%, and its calcium-phosphorus ratio is 2:1. It is more conducive to the absorption and utilization of animals, and the absorption rate can reach 60~70%. Therefore, it is widely used in various foods as a calcium source.
[0004] At present, other common single calcium supplements include inorganic calcium, organic acid calcium, amino acid chelated calcium and peptide chelated calcium. Among them, inorganic calcium such as calcium carbonate and calcium phosphate have the problem of high gastrointestinal irritation to animals and low calcium absorption rate due to their solubility and easy formation of insoluble precipitation in the intestinal environment. Organic acid calcium also has the problem of easy formation of calcium salt precipitation in the intestinal environment. Amino acid chelated calcium and peptide chelated calcium can pass through the small intestinal epithelial cells as a whole to avoid the restriction of calcium ion absorption relying on calcium binding protein, but different amino acids have different calcium loading capacity and affinity with calcium, which may cause low calcium loading or low calcium release efficiency due to their excessive affinity. As a new generation of calcium preparations, peptide chelated calcium has a higher stability, high calcium loading capacity and high bioavailability due to the "small peptide absorption theory", that is, small peptides are the final product of protein digestion, pass through the intestinal mucosal cells as a whole and participate in the systemic circulation. Given that small peptides have more abundant chelating groups, they have higher stability, high calcium loading capacity and high bioavailability.
[0005] However, the inventors have found that in the gastrointestinal environment, peptide chelated calcium is still unstable in acidic and alkaline environments, especially in acidic environments, resulting in the absorption of calcium still needs to be improved. Summary of the invention
[0006] The purpose of the present invention is to add another cyclic dipeptide chelated calcium as a calcium source on the basis of whey calcium as a basic calcium source, so as to further improve the calcium absorption and utilization efficiency of the calcium supplement in animals.
[0007] Based on this, one of the objects of the present invention is to provide a pet milk calcium oral flash disintegrating tablet.
[0008] The second object of the present invention is to provide a method for preparing pet milk calcium oral flash-disintegrating tablets.
[0009] The third object of the present invention is to provide a pet milk calcium oral flash-disintegrating tablet for use in the preparation of animal calcium supplements.
[0010] Specifically, the technical solution of the present invention is as follows: In a first aspect of the present invention, there is provided a pet milk calcium oral flash disintegrating tablet, which comprises, by weight: 10~40 portions of milk calcium; cyclo(ASP-GLY)-calcium chelate 10-30 parts; Filler 10~60 parts; 1-10 parts of disintegrant; 1~10 parts of adhesive; 1~5 parts of lubricant; 0.3~5 parts of flavoring agent.
[0011] Furthermore, the pet milk calcium oral flash disintegrating tablets comprise, by weight: 20-30 portions of milk calcium; cyclo(ASP-GLY)-calcium chelate 15-25 parts; 30~50 parts of filler; 3-7 parts of disintegrant; 3~7 parts of adhesive; 1~5 parts of lubricant; 0.3~5 parts of flavoring agent.
[0012] In some embodiments, the cyclo(ASP-GLY)-calcium chelate is obtained by chelating cyclo(ASP-GLY) with calcium ions.
[0013] The present invention provides a method for preparing the cyclo(ASP-GLY)-calcium chelate, comprising the following steps: A water-soluble calcium salt is added to the cyclo(ASP-GLY) aqueous solution, the pH value of the system is adjusted to 9-11, and the reaction is carried out at a reaction temperature of 40-70°C for 20-80 min to obtain a cyclo(ASP-GLY)-calcium chelate.
[0014] In a specific embodiment, in the cyclo(ASP-GLY) aqueous solution, the concentration of cyclo(ASP-GLY) is 0.5-4 wt %, preferably 1-2 wt %.
[0015] In a specific embodiment, the water-soluble calcium salt can be selected from one or more of calcium chloride (CaCl2), calcium nitrate (Ca(NO)3), and calcium sulfate (Ca(SO)4), preferably calcium chloride. The mass ratio of the soluble calcium salt to cyclo(ASP-GLY) is 20-100:1, preferably 50-70:1.
[0016] In a specific embodiment, the pH of the reaction system can be adjusted using an aqueous sodium hydroxide solution, and its concentration can be 0.5 to 2 M. Preferably, the pH of the system is adjusted to 9.5 to 10.5.
[0017] In a specific embodiment, the reaction temperature is preferably 50-60° C., and the reaction time is preferably 30-50 min.
[0018] In a specific embodiment, the preparation method of cyclo(ASP-GLY)-calcium chelate further comprises a separation and purification step after the reaction is completed, specifically comprising: Add 8 to 20 times the volume of ethanol to the reaction solution, collect the precipitate by centrifugation, continue to wash the precipitate with ethanol and centrifuge, which can be repeated multiple times until there is no free cyclodipeptide and calcium ions in the supernatant; the precipitate is dried to obtain the cyclo(ASP-GLY)-calcium chelate. Preferably, add 8 to 12 times the volume of ethanol to the reaction solution.
[0019] In a further embodiment, the centrifugation is performed at 2000-4000 r / min for 5-20 min. Preferably, the centrifugation is performed at 3000-3500 r / min for 8-12 min.
[0020] In some embodiments, the filler is selected from one or more of mannitol, microcrystalline cellulose, dextran, lactose, and xylitol; preferably, the filler is mannitol.
[0021] In some embodiments, the disintegrant is selected from one or more of sodium carboxymethyl starch, cross-linked polyvinylpyrrolidone (PVPP), cross-linked sodium carboxymethyl cellulose (cCMC-Na), sodium hydroxymethyl cellulose, low-substituted hydroxypropyl cellulose (L-HPC) or dry starch; preferably, the disintegrant is sodium hydroxymethyl cellulose.
[0022] In some embodiments, the lubricant is selected from one or more of silicon dioxide, magnesium stearate, talc, and glyceryl behenate; preferably, the lubricant is magnesium stearate.
[0023] In some embodiments, the binder is selected from one or more of povidone (PVP), starch, gelatin, sodium carboxymethyl cellulose (CMC-Na), and hydroxypropyl methylcellulose. Preferably, the binder is povidone.
[0024] In some embodiments, the flavoring agent is selected from beef flavor, chicken flavor, and sweetener; wherein the sweetener may be sucrose, sorbitol, maltitol, isomalt, sucralose, etc. Preferably, the flavoring agent is beef flavor or chicken flavor.
[0025] In a second aspect of the present invention, a method for preparing the above-mentioned pet milk calcium oral flash-disintegrating tablets is provided, which comprises the following steps: (1) The above-mentioned amounts by weight of lactic calcium, cyclo(ASP-GLY)-calcium chelate, filler, and disintegrant are sieved through a 40-60 mesh sieve and premixed in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix to obtain wet granules, drying, and sieving to obtain granules; (3) Adding the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mixing evenly, and tableting to obtain lactic calcium oral flash disintegrating tablets.
[0026] In the third aspect of the present invention, a use of the above pet milk calcium oral flash disintegrating tablets in the preparation of pet calcium supplements is provided. The pets include: dogs, cats, rabbits, ferrets, mice, etc.
[0027] The present invention has the following beneficial effects:
[0028] The present invention uses cyclo(ASP-GLY) as a chelating agent to chelate calcium ions to obtain cyclo(ASP-GLY)-calcium chelate. The chelate has a large calcium loading capacity and strong stability and is suitable for being used as an effective component of an animal calcium supplement.
[0029] The invention uses whey calcium as a calcium source and adds cyclo(ASP-GLY)-calcium chelate to further improve the calcium absorption and utilization efficiency of the calcium supplement in animals. DETAILED DESCRIPTION
[0030] It should be noted that the following detailed descriptions are illustrative and are intended to provide further explanation of the present application. Unless otherwise specified, all technical and scientific terms used in the present application have the same meanings as those commonly understood by those skilled in the art to which the present application belongs.
[0031] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit the exemplary embodiments according to the present application. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprise" and / or "include" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0032] The following examples are only used to illustrate the embodiments of the present invention and do not constitute any limitation to the present invention. Those skilled in the art will appreciate that various modifications may be made without departing from the spirit and scope of the present invention, and these modifications all fall within the scope of protection of the present invention.
[0033] Reagents and sources:
[0034] cyclo(ASP-GLY): , purchased from Jier Biochemical (Shanghai) Co., Ltd.; cyclo(Ala-Glu): , purchased from Jier Biochemical (Shanghai) Co., Ltd.; ASP-GLY was purchased from Shanghai Yuanye Biotechnology Co., Ltd.; Milk calcium was purchased from Shandong Fengtai Biotechnology Co., Ltd.
[0035] Unless otherwise specified, all reagents used are commercially available, and all equipment and testing methods used are conventional equipment and methods in the art.
[0036] Preparation of cyclo(ASP-GLY)-calcium chelate: Dissolve 0.05 g of cyclo(ASP-GLY) in water to prepare a 2 wt% cyclo(ASP-GLY) aqueous solution, place it in a 55°C water bath, add 1M NaOH aqueous solution to adjust the pH to 10, add 3.0 g of calcium chloride and stir the reaction, keep the reaction temperature at 55°C, and control the pH of the reaction system, and continue stirring the reaction for 40 min. After the reaction is completed, add 10 times the volume of ethanol in the reaction solution, evenly mix and let it stand for precipitation, centrifuge at 3400 r / min for 10 min, collect the precipitate, wash with ethanol and centrifuge for more than 3 times until there is no free cyclodipeptide and calcium ions in the supernatant, and dry the precipitate to obtain cyclo(ASP-GLY)-calcium chelate.
[0037] Preparation of cyclo(Ala-Glu)-calcium chelate: Dissolve 0.05 g of cyclo(Ala-GLY) in water to prepare a 2 wt% cyclo(Ala-GLY) aqueous solution, place it in a 55°C water bath, add 1M NaOH aqueous solution to adjust the pH to 10, add 3.0 g of calcium chloride and stir the reaction, keep the reaction temperature at 55°C, and control the pH of the reaction system, and continue stirring the reaction for 40 min. After the reaction is completed, add 10 times the volume of ethanol in the reaction solution, evenly mix and let it stand for precipitation, centrifuge at 3400 r / min for 10 min, collect the precipitate, wash with ethanol and centrifuge for more than 3 times until there is no free cyclodipeptide and calcium ions in the supernatant, and dry the precipitate to obtain cyclo(Ala-GLY)-calcium chelate.
[0038] Preparation of ASP-GLY-Calcium Chelate: 0.05 g of ASP-GLY dipeptide was dissolved in water to prepare an ASP-GLY dipeptide aqueous solution with a concentration of 2 wt%, which was placed in a 55 °C water bath, and a 1M NaOH aqueous solution was added dropwise to adjust the pH to 10, and 3.0 g of calcium chloride was added to stir the reaction, the reaction temperature was maintained at 55 °C, and the pH of the reaction system was controlled and maintained, and the stirring reaction was continued for 40 min. After the reaction was completed, 10 times the volume of ethanol in the reaction solution was added, and the solution was allowed to stand for precipitation, centrifuged, and the precipitate was dried to obtain ASP-GLY-calcium chelate.
[0039] Determination of calcium content in chelate: The results are shown in Table 1. The determination was carried out by atomic absorption spectrophotometry according to the national standard GB / T5009.92-2003 "Titration method for determination of calcium in food".
[0040] Table 1 Chelated calcium content (wt%) cyclo(ASP-GLY)-Calcium Chelate 12.12% cyclo(Ala-Glu)-calcium chelate 3.36% ASP-GLY-Calcium Chelate 8.55% As shown in Table 1, among the calcium chelates formed with the above two cyclic dipeptides or chain dipeptides as chelating agents, the content of chelated calcium in cyclo(ASP-GLY)-calcium chelate is the highest, reaching more than 12%, and is higher than that of chain ASP-GLY-calcium chelate, while cyclo(Ala-Glu), which is also a cyclic dipeptide, has a weaker chelating ability for calcium.
[0041] Example 1 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 26 cyclo(ASP-GLY)-Calcium Chelate 20 Bulking agent: Mannitol 40.5 Disintegrant: Sodium hydroxymethylcellulose 5 Adhesive: 10% PVP aqueous solution 5 Lubricant: Magnesium stearate 3 Flavoring agent: chicken flavor 0.5 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) After passing the above-prescribed amount of lactic calcium, cyclo(ASP-GLY)-calcium chelate, filler, and disintegrant through a 50-mesh sieve, premix them in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying them, and sieving them to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-1.
[0042] Example 2 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 10 cyclo(ASP-GLY)-Calcium Chelate 10 Bulking agent: Mannitol 10 Disintegrant: Sodium hydroxymethylcellulose 1 Adhesive: 10% PVP aqueous solution 1 Lubricant: Magnesium stearate 1 Flavoring agent: chicken flavor 0.3 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) After passing the above-prescribed amount of lactic calcium, cyclo(ASP-GLY)-calcium chelate, filler, and disintegrant through a 50-mesh sieve, premix them in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying, and sieving to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-2.
[0043] Example 3 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 40 cyclo(ASP-GLY)-Calcium Chelate 30 Bulking agent: Mannitol 60 Disintegrant: Sodium hydroxymethylcellulose 10 Adhesive: 10% PVP aqueous solution 10 Lubricant: Magnesium stearate 5 Flavoring agent: chicken flavor 5 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) After passing the above-prescribed amount of lactic calcium, cyclo(ASP-GLY)-calcium chelate, filler, and disintegrant through a 50-mesh sieve, premix them in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying them, and sieving them to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-3.
[0044] Comparative Example 1 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 46 Bulking agent: Mannitol 40.5 Disintegrant: Sodium hydroxymethylcellulose 5 Adhesive: 10% PVP aqueous solution 5 Lubricant: Magnesium stearate 3 Flavoring agent: chicken flavor 0.5 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) After passing the above-prescribed amount of lactic calcium, filler, and disintegrant through a 50-mesh sieve, premix the mixture in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying, and sieving to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-4.
[0045] Comparative Example 2 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 26 cyclo(Ala-Glu)-calcium chelate 20 Bulking agent: Mannitol 40.5 Disintegrant: Sodium hydroxymethylcellulose 5 Adhesive: 10% PVP aqueous solution 5 Lubricant: Magnesium stearate 3 Flavoring agent: chicken flavor 0.5 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) Premixing the above-prescribed amounts of lactic calcium, cyclo(Ala-Glu)-calcium chelate, filler, and disintegrant in a high-speed premixer after passing through a 50-mesh sieve to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying, and sieving to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-5.
[0046] Comparative Example 3 Preparation of lactic calcium oral flash disintegrating tablets: prescription: Components Weight Milk calcium 26 ASP-GLY-Calcium Chelate 20 Bulking agent: Mannitol 40.5 Disintegrant: Sodium hydroxymethylcellulose 5 Adhesive: 10% PVP aqueous solution 5 Lubricant: Magnesium stearate 3 Flavoring agent: chicken flavor 0.5 Using the above prescription, prepare flash disintegrating tablets according to the following steps: (1) After passing the above-prescribed amount of milk calcium, ASP-GLY-calcium chelate, filler, and disintegrant through a 50-mesh sieve, premix them in a high-speed premixer to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in (1) to obtain wet granules, drying, and sieving to obtain granules; (3) Add the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mix well, and press into tablets to obtain lactic calcium oral flash disintegrating tablets-6.
[0047] Test Example: The calcium supplement effect test of the lactic calcium oral flash disintegrating tablets prepared in Example 1 and Comparative Examples 1 to 3 was conducted using a calcium-deficient rat model. The specific test scheme is as follows: (1) Experimental animals: 4-week-old weaned rats (average weight 70-90 g) were selected. The animals were kept and observed for 7 days before the experiment to adapt to the breeding environment. The breeding conditions were 20℃~25℃ and 40%-60% humidity. The rats were allowed to drink deionized water freely during the whole experiment.
[0048] (2) Grouping, feeding and drug administration: A total of 112 rats (half male and half female) were divided into 7 groups, namely normal control group, low calcium feeding control group, calcium carbonate group, lactic calcium oral flash disintegrating tablets-1 group, lactic calcium oral flash disintegrating tablets-4 group, lactic calcium oral flash disintegrating tablets-5 group, and lactic calcium oral flash disintegrating tablets-6 group.
[0049] The normal control group was fed with ordinary feed (calcium content of 5000 mg / kg), the low-calcium feeding group was fed with low-calcium feed (calcium content of 1000 mg / kg), and the drug-treated groups (calcium carbonate group, lactic calcium oral flash-disintegrating tablets-1 group, lactic calcium oral flash-disintegrating tablets-4 group, lactic calcium oral flash-disintegrating tablets-5 group, lactic calcium oral flash-disintegrating tablets-6 group) started drug administration after being fed with low-calcium feed for four weeks, and continued to be given low-calcium feed.
[0050] The drug-treated group was intragastrically administered with a dose of 20 mg / 100 g of calcium (administered after dissolving or dispersing the preparation in deionized water) once a day for four weeks.
[0051] (3) Criteria (i) Body weight: The mice were weighed once a week, and the weight changes before and after oral administration were calculated. The mice were weighed before the end of the experiment, and the weight gain rate was calculated.
[0052] (ii) Serum calcium: After four weeks of drug administration, the tails of rats in each group were cut off to collect blood, and the blood calcium content was measured using an automatic biochemical analyzer.
[0053] (iii) Apparent calcium absorption rate: Three days before the end of the experiment, the feces of the rats were collected and the calcium content therein was determined by atomic absorption spectrophotometry. The apparent calcium absorption rate was calculated according to the following formula.
[0054] Apparent calcium absorption rate (%) = (calcium intake - fecal calcium) / calcium intake × 100% (4) Results The results of each indicator are shown in Table 2.
[0055] Table 2 Group Weight gain rate (%) Serum calcium (mmol / L) Calcium intake (mg / d) Fecal calcium (mg / d) Apparent calcium absorption rate (%) Normal control group 18.51±1.82 2.65±0.15 48.25±1.96 25.31±4.25 46.24±5.62 Low calcium feeding control group 12.32±2.51 2.07±0.24 9.28±1.84 1.66±0.52 82.49±2.35 Calcium carbonate group 15.46±2.35 2.45±0.17 48.52±2.1 28.75±5.46 39.57±6.58 Flash collapse tablets - 1 set 18.22±2.48 2.74±0.23 48.31±1.95 9.07±4.57 <![CDATA[80.46±5.24 abc ]]> Flash Crash Tablets-4 Groups 17.62±3.14 2.63±0.26 48.28±2.54 13.85±4.69 <![CDATA[70.51±5.96 d ]]> Flash Tablets-5 Groups 16.14±2.63 2.58±0.21 48.34±1.86 18.27±5.23 61.41±6.36 Flash Tablets-6 Groups 17.45±2.18 2.61±0.18 48.41±1.82 12.17±4.61 73.54±5.84 Among them, a means compared with the flash collapse tablet-4 group, p < 0.01; b means compared with the flash collapse tablet-5 group, p < 0.001; c means compared with the flash collapse tablet-6 group, p < 0.05; d means compared with the flash collapse tablet-4 group, p < 0.01 As shown in Table 2, the flash disintegrating tablets (flash disintegrating tablets-1 group) added with cyclo(ASP-GLY)-calcium chelate showed the best weight gain, serum calcium content and apparent calcium absorption rate in each administration group, especially the data of calcium apparent absorption rate were significantly different from other groups, which shows that cyclo(ASP-GLY)-calcium chelate has better properties in calcium absorption and utilization on the basis of high calcium loading. In particular, by comparing Comparative Example 3 with Example 1, the inventors found that cyclo(ASP-GLY)-calcium chelate is superior to chain ASP-GLY-calcium chelate in the above aspects, which may be due to the free carboxyl group in cyclo(ASP-GLY) and the group position on the 2,5-diketopiperazine ring are more conducive to the chelation of calcium ions, which is manifested in a higher calcium loading and higher stability in the acidic environment of the stomach, thereby facilitating calcium absorption and utilization. By comparing Comparative Example 2 with Example 1, the inventors also found that cyclo(Ala-Glu)-calcium chelate, which is also a cyclic dipeptide, not only performs poorly in terms of calcium loading, but the preparation added with it (flash-disintegrating tablet-5) also performs poorly in calcium absorption and utilization, and is even worse than flash-disintegrating tablet-3 added with only lactic calcium. This shows that not all cyclic dipeptides play a positive role in calcium loading and calcium absorption and utilization in the body.
[0056] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A pet milk calcium oral disintegrating tablet, characterized in that: It comprises, by weight: 10~40 portions of milk calcium; cyclo(ASP-GLY)-calcium chelate 10-30 parts; Filler 10~60 parts; 1-10 parts of disintegrant; 1~10 parts of adhesive; 1~5 parts of lubricant; 0.3~5 parts of flavoring agent.
2. The pet milk calcium oral flash disintegrating tablet according to claim 1, characterized in that It comprises, by weight: 20-30 portions of milk calcium; cyclo(ASP-GLY)-calcium chelate 15-25 parts; 30~50 parts of filler; 3-7 parts of disintegrant; 3~7 parts of adhesive; 1~5 parts of lubricant; 0.3~5 parts of flavoring agent.
3. The pet milk calcium oral disintegrating tablet according to claim 1, characterized in that The cyclo(ASP-GLY)-calcium chelate is obtained by chelating cyclo(ASP-GLY) with calcium ions.
4. The pet milk calcium oral disintegrating tablet according to claim 3, characterized in that: The preparation method of the cyclo(ASP-GLY)-calcium chelate comprises: A water-soluble calcium salt is added to the cyclo(ASP-GLY) aqueous solution, the pH value of the system is adjusted to 9-11, and the reaction is carried out at a reaction temperature of 40-70°C for 20-80 min to obtain a cyclo(ASP-GLY)-calcium chelate.
5. The pet milk calcium oral flash disintegrating tablet according to claim 1, characterized in that The filler is selected from one or more of mannitol, microcrystalline cellulose, dextran, lactose and xylitol.
6. The pet milk calcium oral disintegrating tablet according to claim 1, characterized in that: The disintegrant is selected from one or more of sodium carboxymethyl starch, cross-linked polyvinylpyrrolidone, cross-linked sodium carboxymethyl cellulose, sodium hydroxymethyl cellulose, low-substituted hydroxypropyl cellulose or dry starch.
7. The pet milk calcium oral disintegrating tablet according to claim 1, characterized in that: The lubricant is selected from one or more of silicon dioxide, magnesium stearate, talc, and glyceryl behenate.
8. The pet milk calcium oral disintegrating tablet according to claim 1, characterized in that: The binder is selected from one or more of povidone, starch, gelatin, sodium carboxymethyl cellulose, and hydroxypropyl methyl cellulose.
9. A method for preparing the pet milk calcium oral flash-disintegrating tablets according to any one of claims 1 to 8, comprising the following steps: (1) Premixing the above-prescribed amounts of lactic calcium, cyclo(ASP-GLY)-calcium chelate, filler, and disintegrant in a high-speed premixer after passing through a 40-60 mesh sieve to obtain a uniformly mixed premix; (2) spraying the binder aqueous solution into the uniformly mixed premix obtained in step (1) to obtain wet granules, drying them, and sieving them to obtain granules; (3) Adding the prescribed amount of lubricant and flavoring agent to the granules obtained in step (2), mixing evenly, and tableting to obtain lactic calcium oral flash disintegrating tablets.
10. Use of the pet milk calcium oral flash-disintegrating tablets according to any one of claims 1 to 8 in the preparation of pet calcium supplements.
Citation Information
Patent Citations
Food and beverages containing cyclo(aspartyl-glycine), glucose, and maltose
CN110099574A
Calcium agent
WO2015020191A1
